Entourage Health (CVE:ENTG) Reaches New 12-Month Low – Should You Sell?

Entourage Health Corp. (CVE:ENTGGet Free Report) shares reached a new 52-week low during mid-day trading on Monday . The stock traded as low as C$0.01 and last traded at C$0.01, with a volume of 14195 shares traded. The stock had previously closed at C$0.02.

Entourage Health Stock Performance

The stock has a market cap of C$3.08 million, a price-to-earnings ratio of -0.07 and a beta of 1.08. The company has a debt-to-equity ratio of 2,914.72, a quick ratio of 0.91 and a current ratio of 0.10. The stock has a fifty day simple moving average of C$0.01 and a two-hundred day simple moving average of C$0.01.

About Entourage Health

(Get Free Report)

Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary’s Medicinals, and Royal City Cannabis brand names.

Featured Articles

Receive News & Ratings for Entourage Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entourage Health and related companies with MarketBeat.com's FREE daily email newsletter.